1. Home
  2. ALLR vs TKLF Comparison

ALLR vs TKLF Comparison

Compare ALLR & TKLF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALLR
  • TKLF
  • Stock Information
  • Founded
  • ALLR 2004
  • TKLF 2006
  • Country
  • ALLR United States
  • TKLF Japan
  • Employees
  • ALLR N/A
  • TKLF N/A
  • Industry
  • ALLR Biotechnology: Pharmaceutical Preparations
  • TKLF Other Specialty Stores
  • Sector
  • ALLR Health Care
  • TKLF Consumer Discretionary
  • Exchange
  • ALLR Nasdaq
  • TKLF Nasdaq
  • Market Cap
  • ALLR 13.3M
  • TKLF 16.0M
  • IPO Year
  • ALLR N/A
  • TKLF 2022
  • Fundamental
  • Price
  • ALLR $1.00
  • TKLF $3.56
  • Analyst Decision
  • ALLR
  • TKLF
  • Analyst Count
  • ALLR 0
  • TKLF 0
  • Target Price
  • ALLR N/A
  • TKLF N/A
  • AVG Volume (30 Days)
  • ALLR 464.0K
  • TKLF 10.6K
  • Earning Date
  • ALLR 08-04-2025
  • TKLF 07-15-2025
  • Dividend Yield
  • ALLR N/A
  • TKLF N/A
  • EPS Growth
  • ALLR N/A
  • TKLF N/A
  • EPS
  • ALLR N/A
  • TKLF 1.70
  • Revenue
  • ALLR N/A
  • TKLF $219,520,631.00
  • Revenue This Year
  • ALLR N/A
  • TKLF N/A
  • Revenue Next Year
  • ALLR N/A
  • TKLF N/A
  • P/E Ratio
  • ALLR N/A
  • TKLF $2.18
  • Revenue Growth
  • ALLR N/A
  • TKLF 32.02
  • 52 Week Low
  • ALLR $0.61
  • TKLF $2.20
  • 52 Week High
  • ALLR $7.45
  • TKLF $8.53
  • Technical
  • Relative Strength Index (RSI)
  • ALLR 54.51
  • TKLF 51.46
  • Support Level
  • ALLR $0.80
  • TKLF $3.20
  • Resistance Level
  • ALLR $1.09
  • TKLF $3.85
  • Average True Range (ATR)
  • ALLR 0.07
  • TKLF 0.20
  • MACD
  • ALLR 0.02
  • TKLF -0.02
  • Stochastic Oscillator
  • ALLR 63.03
  • TKLF 60.93

About ALLR Allarity Therapeutics Inc.

Allarity Therapeutics Inc is a clinical-stage, precision medicine pharmaceutical company focused on developing novel anti-cancer therapeutics for patients with high unmet medical needs. The company is actively advancing the development of stenoparib, an orally available, small-molecule inhibitor for patients with advanced recurrent ovarian cancer. It is leveraging its proprietary Drug Response Predictor (DRP) technology to refine patient selection and improve clinical outcomes. The company operates as a single operating and reporting segment (developing a treatment for ovarian cancer) in two geographic areas: Denmark and the United States.

About TKLF Yoshitsu Co. Ltd

Tokyo Lifestyle Co Ltd, formerly Yoshitsu Co Ltd is a retailer and wholesaler of Japanese beauty and health products, as well as other products. Its products include cosmetics, skincare, fragrance, and body care. The company's segment includes Directly-Operated Physical Stores; Online Stores and Services; and Franchise Stores and Wholesale Customers. The company generates maximum revenue from the Franchise Stores and Wholesale Customers segment. Geographically, the company generates maximum revenue from China followed by Japan and other overseas markets.

Share on Social Networks: